These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31818725)

  • 1. Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?
    Kocabeyoglu SS; Kervan U; Emre Sert D; Temizhan A; Demirkan B; Aygun E; Akdi M; Pac M
    Heart Lung Circ; 2020 Jul; 29(7):1039-1045. PubMed ID: 31818725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.
    Braun S; Schrötter H; Schmeisser A; Strasser RH
    Int J Cardiol; 2007 Jan; 115(1):67-72. PubMed ID: 16797747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
    Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J
    Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
    Antoniou T; Prokakis C; Athanasopoulos G; Thanopoulos A; Rellia P; Zarkalis D; Kogerakis N; Koletsis EN; Bairaktaris A
    Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
    Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantation.
    Duszańska A; Wasilewski J; Gierlotka M; Zakliczyński M
    Adv Med Sci; 2020 Sep; 65(2):298-303. PubMed ID: 32454454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation.
    Sabato LA; Salerno DM; Moretz JD; Jennings DL
    Pharmacotherapy; 2017 Aug; 37(8):944-955. PubMed ID: 28543813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study.
    Gall H; Sommer N; Milger K; Richter MJ; Voswinckel R; Bandorski D; Seeger W; Grimminger F; Ghofrani HA
    BMC Pulm Med; 2016 Jan; 16():5. PubMed ID: 26753921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.
    Theodoraki K; Thanopoulos A; Rellia P; Leontiadis E; Zarkalis D; Perreas K; Antoniou T
    Heart Vessels; 2017 Dec; 32(12):1488-1497. PubMed ID: 28717881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation.
    Lopez-Meseguer M; Berastegui C; Monforte V; Bravo C; Domingo E; Roman A
    Transplant Proc; 2013; 45(6):2347-50. PubMed ID: 23953548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.
    Sablotzki A; Czeslick E; Schubert S; Friedrich I; Mühling J; Dehne MG; Grond S; Hentschel T
    Can J Anaesth; 2002 Dec; 49(10):1076-80. PubMed ID: 12477682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SPECIFICS OF INHALED ILOPROST PHARMACODYNAMICS IN PATIENTS WITH SEVERE LEFT VENTRICULAR SYSTOLIC DYSFUNCTION].
    Bautin AE; Iakovlev AS; Tashkhanov DM; Datsenko SV; Marichev AO; Popov MA; Fedotov PA
    Anesteziol Reanimatol; 2015; 60(2):4-7. PubMed ID: 26148353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates--experiences with 45 cases.
    Sablotzki A; Hentschel T; Hofmann S; Simm A; Mühling J; Czeslick E
    J Clin Anesth; 2006 Mar; 18(2):108-13. PubMed ID: 16563327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].
    Rabanal Llevot JM; Cimadevilla Calvo B; Cifrian Martinez JM; Ruisanchez Villar C; Mons Lera R
    Rev Esp Anestesiol Reanim; 2012 Mar; 59(3):142-9. PubMed ID: 22985755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-induced pulmonary hypertension: different impact of iloprost, sildenafil, and nitric oxide.
    Weissmann N; Gerigk B; Kocer O; Nollen M; Hackemack S; Ghofrani HA; Schermuly RT; Butrous G; Schulz A; Roth M; Seeger W; Grimminger F
    Respir Med; 2007 Oct; 101(10):2125-32. PubMed ID: 17643279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates.
    Tavares-Silva M; Saraiva F; Pinto R; Amorim S; Silva JC; Leite-Moreira AF; Maciel MJ; Lourenço AP
    ESC Heart Fail; 2021 Apr; 8(2):908-917. PubMed ID: 33621427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.